France, a G7 member state, has been a donor to Gavi since 2004 and has contributed to the Vaccine Alliance through direct contributions and the International Finance Facility for Immunisation (IFFIm), which it helped establish, and of which it is currently the second largest donor.
A long-standing champion of innovative financing, equitable access to vaccines and stronger health systems, France has steadily increased its support to Gavi over the past two decades. During the COVID-19 pandemic, France played a leading role in advancing vaccine equity, becoming the first country to donate vaccine doses through COVAX.
France further demonstrated its commitment to global health by maintaining health as a priority during its 2026 G7 Presidency. In June 2024, France co-hosted, alongside the African Union and Gavi, the launch of Gavi's Investment Opportunity for 2026–2030 and the African Vaccine Manufacturing Accelerator (AVMA), an innovative mechanism designed to strengthen vaccine manufacturing capacity across Africa, where President Macron reaffirmed France’s intention to at least maintain its level of support to Gavi in the 2026–2030 strategic period.
In June 2025, France committed €500 million to Gavi’s 2026–2030 strategy, including a recommitment to IFFIm. France has also contributed US$ 100 million to AVMA and US$ 5 million to the First Response Fund
*Local currency
†Proceeds are the funds that Gavi receives from donor commitments, either through direct donor payments, funding raised in advance against future donor pledges through IFFIm, or AMC funds released by the World Bank.
Hover over the bar chart above to view the data
Direct Contributions (including Matching Fund)
Non-US$ contributions are converted to US$ as follows:
IFFIm Contributions
Non-US$ contributions are converted to US$ as follows: